Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: A meta-analysis

Journal of Women's Health

Volumn 20, Issue 6, 2011, Pages 845-852

  Magnus, Maria C ^a   Ping, Ma ^a   Shen, Miao Miao ^a   Bourgeois, John ^a   Magnus, Jeanette H ^a  

^a TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER MORTALITY; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; META ANALYSIS; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS;

ADULT; AGE FACTORS; ANXIETY; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY;

EID: 79959299466     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2010.2098     Document Type: Article

References (63)

1. Jatoi I, Chen BE, Anderson WF, Rosenberg PS. Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 2007;25:1683-1690. (Pubitemid 46797948)
2. Shen Y, Yang Y, Inoue LY, Munsell MF, Miller AB, Berry DA. Role of detection method in predicting breast cancer survival: Analysis of randomized screening trials. J Natl Cancer Inst 2005;97:1195-1203. (Pubitemid 41258225)
3. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:347-360.
4. Keen JD, Keen JE. What is the point: Will screening mammography save my life? BMC Med Inform Decis Mak 2009;9:18.
5. Davis WW, Parsons VL, Xie D, et al. State-based estimates of mammography screening rates based on information from two health surveys. Public Health Rep 2010;125:567-578.
6. Campbell RT, Li X, Dolecek TA, Barrett RE, Weaver KE, Warnecke RB. Economic, racial and ethnic disparities in breast cancer in the U.S.: Towards a more comprehensive model. Health Place 2009;15:855-864.
7. Kim J, Jang SN. Socioeconomic disparities in breast cancer screening among U.S. women: Trends from 2000 to 2005. J Prev Med Public Health 2008;41:186-194.
8. Tian N, Gaines Wilson J, Benjamin Zhan F. Female breast cancer mortality clusters within racial groups in the United States. Health Place 2010;16:209-218.
9. Kearney AJ, Murray M. Breast cancer screening recommendations: Is mammography the only answer? J Midwifery Womens Health 2009;54:393-400.
10. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: An update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:727-737.
11. Chalmers TC, Smith H Jr, Blackburn B, et al. A method for assessing the quality of a randomized control trial. Control Clin Trials 1981;2:31-49. (Pubitemid 11083624)
12. Chu KC, Smart CR, Tarone RE. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst 1988;80:1125-1132.
13. Moss S. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group. J Med Screen 1999;6:144-148. (Pubitemid 29526262)
14. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: Updated overview of the Swedish randomised trials. Lancet 2002;359:909-919. (Pubitemid 34246378)
15. Andersson I, Janzon L. Reduced breast cancer mortality in women under age 50: Updated results from the Malmo Mammographic Screening Program. J Natl Cancer Inst Monogr 1997;22:63-67.
16. Duffy SW, Tabar L, Vitak B, et al. The Swedish Two-County Trial of mammographic screening: Cluster randomisation and end point evaluation. Ann Oncol 2003;14:1196-1198. (Pubitemid 37039040)
17. Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Follow-up after 11 years - Update of mortality results in the Stockholm Mammographic Screening Trial. Breast Cancer Res Treat 1997;45:263-270. (Pubitemid 27453795)
18. Bjurstam N, Bjorneld L, Warwick J, et al. The Gothenburg Breast Screening Trial. Cancer 2003;97:2387-2396. (Pubitemid 36542476)
19. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: The Malmo Mammographic Screening Trial. BMJ 1988;297:943-948.
20. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammography screening - Preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991;18:49-56.
21. Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A. Screening for breast cancer in women aged under 50: Mode of detection, incidence, fatality, and histology. J Med Screen 1995;2:94-98.
22. Tabar L, Fagerberg G, Duffy SW, Day NE. The Swedish Two-County Trial of mammographic screening for breast cancer: Recent results and calculation of benefit. J Epidemiol Community Health 1989;43:107-114. (Pubitemid 19147295)
23. Bjurstam N, Bjorneld L, Duffy SW, et al. The Gothenburg Breast Cancer Screening Trial: Preliminary results on breast cancer mortality for women aged 39-49. J Natl Cancer Inst Monogr 1997;22:53-55.
24. Bjurstam N, Bjorneld L, Duffy SW, et al. The Gothenburg Breast Screening Trial: First results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer 1997;80:2091-2099. (Pubitemid 27506022)
25. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992;147:1459-1476.
26. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: A randomised controlled trial. Lancet 2006;368:2053-2060. (Pubitemid 44855105)
27. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Selection, follow-up, and analysis in the Health Insurance Plan Study: A randomized trial with breast cancer screening. Natl Cancer Inst Monogr 1985;67:65-74. (Pubitemid 15031263)
28. Alexander FE, Anderson TJ, Brown HK, et al. Fourteen years of follow-up from the Edinburgh randomised trial of breast cancer screening. Lancet 1999;353:1903-1908. (Pubitemid 29255701)
29. Shapiro S. Periodic screening for breast cancer: The HIP Randomized Controlled Trial. Health Insurance Plan. J Natl Cancer Inst Monogr 1997;22:27-30.
30. Alexander FE, Anderson TJ, Brown HK, et al. The Edinburgh randomised trial of breast cancer screening: Results after 10 years of follow-up. Br J Cancer 1994;70:542-548. (Pubitemid 24268562)
31. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: Breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002;137:305-312.
32. Moss S, Thomas I, Evans A, Thomas B, Johns L. Randomised controlled trial of mammographic screening in women from age 40: Results of screening in the first 10 years. Br J Cancer 2005;92:949-954. (Pubitemid 40462644)
33. Mettlin CJ, Smart CR. The Canadian National Breast Screening Study. An appraisal and implications for early detection policy. Cancer 1993;72(Suppl 4):1461-1465.
34. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69:349-355. (Pubitemid 12018584)
35. Glasziou PP, Woodward AJ, Mahon CM. Mammographic screening trials for women aged under 50. A quality assessment and meta-analysis. Med J Aust 1995;162:625-629.
36. Smart CR, Hendrick RE, Rutledge JH 3rd, Smith RA. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer 1995;75:1619-1626.
37. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA 1995;273:149-154.
38. Kerlikowske K. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: Comparison of relative and absolute benefit. J Natl Cancer Inst Monogr 1997;22:79-86.
39. Hendrick RE, Smith RA, Rutledge JH 3rd, Smart CR. Benefit of screening mammography in women aged 40-49: A new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997;22:87-92.
40. Glasziou P, Irwig L. The quality and interpretation of mammographic screening trials for women ages 40-49. J Natl Cancer Inst Monogr 1997;22:73-77.
41. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-134.
42. Tabar L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA. Beyond randomized controlled trials: Organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001;91:1724-1731. (Pubitemid 32377958)
43. Kadiyala S. Are U.S. cancer screening test patterns consistent with guideline recommendations with respect to the age of screening initiation? BMC Health Serv Res 2009;9:185.
44. Nelson HD, Fu R, Griffin JC, Nygren P, Smith ME, Humphrey L. Systematic review: Comparative effectiveness of medications to reduce risk for primary breast cancer. Ann Intern Med 2009;151:703-715.
45. Olsen O, Gotzsche PC. Cochrane Review on screening for breast cancer with mammography. Lancet 2001;358:1340-1342. (Pubitemid 33016501)
46. Anderson TJ, Waller M, Ellis IO, Bobrow L, Moss S. Influence of annual mammography from age 40 on breast cancer pathology. Hum Pathol 2004;35:1252-1259.
47. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: Model estimates of potential benefits and harms. Ann Intern Med 2009;151:738-747.
48. DeAngelis CD, Fontanarosa PB. US Preventive Services Task Force and breast cancer screening. JAMA 2010;303:172-173.
49. Schopper D, de Wolf C. How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer 2009;45:1916-1923.
50. Hackshaw A. EUSOMA review of mammography screening. Ann Oncol 2003;14:1193-1195. (Pubitemid 37039039)
51. Woloshin S, Schwartz LM. The benefits and harms of mammography screening: Understanding the trade-offs. JAMA 2010;303:164-165.
52. Welch HG, Schwartz LM, Woloshin S. Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers. BMJ 2006;332:727. (Pubitemid 44365697)
53. Woolf SH. The 2009 Breast Cancare Screening Recommendations of the U.S. Preventive Services Task Force. JAMA 2010;303:162-163.
54. Murphy AM. Mammogrsphy screening for breast cancer. JAMA 2010;303:166-167.
55. Truog RD. Screening mammography and the "r" word. N Engl J Med 2009;361:2501-2503.
56. Partridge AH, Winer EP. On mammography - More agreement than disagreement. N Engl J Med 2009;361:2499-2501.
57. Margolies L. Mammographic screening for breast cancer: 2010. Mt Sinai J Med 2010;77:398-404.
58. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333. (Pubitemid 34761611)
59. Kinsey T, Jemal A, Liff J, Ward E, Thun M. Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst 2008;100:1003-1012.
60. Weigel S, Batzler WU, Decker T, Hense HW, Heindel W. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of populationbased digital mammography screening. Rofo 2009;181:1144-1150.
61. Krieger N, Chen JT, Waterman PD. Decline in U.S. breast cancer rates after the Women's Health Initiative: Socio-economic and racial/ethnic differentials. Am J Public Health [epub ahead of print February 2010]
62. Summers C, Saltzstein SL, Blair SL, Tsukamoto TT, Sadler GR. Racial/ethnic differences in early detection of breast cancer: A study of 250,985 cases from the California cancer registry. J Womens Health 2010;19:203-207.
63. Nekhlyudov L, Braddock CH 3rd. An approach to enhance communication about screening mammography in primary care. J Womens Health 2009;18:1403-1412.